, a leading global medical technology company, we delved into the transformative world of self-collection in women's healthcare. This groundbreaking approach to healthcare is poised to change the way we approach cervical cancer screening, making it more accessible and convenient for women across the United States.
“I think there was some trepidation initially about nasal swabbing yourself to test for COVID-19. But then people got used to it and there was an almost instantaneous interest in, ‘Hey, what else could I self-collect for or even self-test for?’ In addition, because of the pandemic, the government accelerated the work toward the support of telemedicine.
to conduct clinical trials that validate self-collection methods, ensuring they meet FDA requirements.